Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q4

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth quarter financial results, and data on their orthopedic sales.

Advertisement

Here is how their fourth-quarter finances compare:

Stryker 

Total sales: $5.2 billion (+10.7 percent) 

Orthopedics and spine: $2.1 billion (+4.3 percent) 

Hips: $375 million (+6.7 percent)

Knees: $552 million (+5.4 percent)

Johnson & Johnson

Total sales: $23.7 billion (-4.4 percent)

Spine, sports and other: $699 million (-1.3 percent) 

Orthopedic: $2.1 billion (-0.4 percent) 

Hips: $385 million (+1.7 percent)

Knees: $354 million (+3.4 percent)

Zimmer Biomet

Total sales: $1.8 billion (+2.7 percent)

Hips: $488.7 million (+1.7 percent) 

Knees: $753.6 million (+4.7 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $424.2 million (+3.3 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.